HMG-I/HMG-Y siRNA (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemHMG-I/HMG-Y siRNA (h)
CompanySanta Cruz Biotechnology, Inc.
Price $293.00Supplier Page View Company Product Page
Catalog Numbersc-37115
Quantity10 µM
Gene Namehigh mobility group AT-hook 1
Specieshuman
TypesiRNA/dsRNA
NCBI Full Gene Namehigh mobility group AT-hook 1
NCBI Gene AliasesHMG-R, HMGA1A, HMGIY

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) HMGA1 deficiency: a pathogenic link between tau pathology and insulin resistanceEBioMedicineApril 14, 2025Maria Mirabelli, Eusebio Chiefari, Biagio Arcidiacono, Alessandro Salatino, Angelo Pascarella, Maurizio Morelli, Sara C. Credendino, Francesco S. Brunetti, Anna Di Vito, Adelaide Greco, et al.using the dual-luciferase reporter assay system (Promega). siRNA oligonucleotides targeting HMGA1 (sc-37115; Santa Cruz Biotechnology) and nonspecific siRNA controls with a similar GC content (Dharmacon) (100–200

(2) Apelin-mediated deamidation of HMGA1 promotes tumorigenesis by enhancing SREBP1 activity and lipid synthesisCancer scienceNovember 1, 2022Zhu Y, Yang Y, Bu H, Huang H, Chen H, Ran J, Qin L, Ni Y, Yao M, Song T, et al.transfection All plasmids were constructed by Genecopoeia. siRNAs targeting SREBP1 (sc‐36557) and HMGA1 (sc‐37115) were purchased from Santa Cruz. The siRNA against CAD and APJ were designed and synthesized by RiboBio. 2.4

(3) Cross-talk among HMGA1 and FoxO1 in control of nuclear insulin signalingScientific reportsJune 4, 2018Chiefari E, Arcidiacono B, Palmieri C, Corigliano DM, Morittu VM, Britti D, Armoni M, Foti DP, Brunetti A.Biosystems Inc.), using the dual-luciferase reporter assay system (Promega). siRNA targeted to human HMGA1 (sc-37115) was purchased from Santa Cruz Biotechnology, whereas nonspecific siRNA controls with a similar GC content

(4) HMGA1 is a novel transcriptional regulator of the FoxO1 geneEndocrineApril 1, 2018Arcidiacono B, Chiefari E, Messineo S, Bilotta FL, Pastore I, Corigliano DM, Foti DP, Brunetti A.

(5) A polymorphism of HMGA1 protects against proliferative diabetic retinopathy by impairing HMGA1-induced VEGFA expressionScientific reportsDecember 19, 2016Chiefari E, Ventura V, Capula C, Randazzo G, Scorcia V, Fedele M, Arcidiacono B, Nevolo MT, Bilotta FL, Vitiello M, et al.

(6) Cooperation between HMGA1, PDX-1, and MafA is Essential for Glucose-Induced Insulin Transcription in Pancreatic Beta CellsFrontiers in endocrinologyJanuary 1, 2014Arcidiacono B, Iiritano S, Chiefari E, Brunetti FS, Gu G, Foti DP, Brunetti A.

(7) Functional relationship between high mobility group A1 (HMGA1) protein and insulin-like growth factor-binding protein 3 (IGFBP-3) in human chondrocytesArthritis research & therapyOctober 4, 2012Gasparini G, De Gori M, Paonessa F, Chiefari E, Brunetti A, Galasso O.

Be the First to Write a Review!

HMG-I/HMG-Y siRNA (h)

HMG-I/HMG-Y siRNA (h) from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (7)

Reviews

HMG-I/HMG-Y siRNA (h) from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map